Aetna modified CPB 0753 covering core decompression for avascular necrosis, effective November 1, 2025. Here's what billing teams need to know.

Aetna, a CVS Health company, updated its core decompression coverage policy under CPB 0753 in the Aetna system. The policy governs reimbursement for HCPCS S2325 (hip core decompression) and a range of adjunctive procedures billed under CPT codes including 0101T, 0232T, 0481T, and 38232. The update sharpens the line between covered and experimental indications — and that line has real claim denial exposure for orthopedic and surgical billing teams.


Quick-Reference: Aetna CPB 0753 Core Decompression Policy (2025)

Field Detail
Payer Aetna, a CVS Health company
Policy Core Decompression for Avascular Necrosis
Policy Code CPB 0753
Change Type Modified
Effective Date November 1, 2025
Impact Level High
Specialties Affected Orthopedic surgery, sports medicine, interventional radiology, hematology/oncology
Key Action Audit all core decompression claims for stage documentation — only Ficat Stage I or II femoral head AVN qualifies for coverage under S2325

Aetna Core Decompression Coverage Criteria and Medical Necessity Requirements 2025

The Aetna core decompression coverage policy is narrow. Medical necessity applies to exactly one scenario: early-stage avascular necrosis (AVN) of the hip — specifically the femoral head and/or neck — at Ficat Stage I or II, before X-ray changes are evident.

That's it. One joint. Two stages. Everything else is experimental.

Your documentation has to establish pre-collapse status at the time of service. Aetna uses the Ficat Classification to define staging. Under that system, cysts on imaging push a patient into Stage II — still covered. Stage III or higher means post-collapse, and that's where medical necessity ends under this policy.

The practical takeaway: if the operative or diagnostic record doesn't clearly state Ficat staging, your claim for S2325 is exposed. Don't let your billing team submit without that staging language in the supporting documentation. If your practice doesn't routinely document Ficat stage in the surgical note, fix that workflow before November 1, 2025.

Aetna's core decompression billing guidelines don't explicitly call out prior authorization requirements within CPB 0753 itself, but prior auth requirements can vary by plan. Check the member's specific plan documents before scheduling. Assuming no prior auth is required for a surgical procedure is a fast path to a claim denial.


Aetna Core Decompression Exclusions and Non-Covered Indications

This is where CPB 0753 gets long — and where most denials will come from.

Aetna classifies core decompression as experimental, investigational, or unproven for AVN in any joint other than the hip. That means ankle, elbow, knee, mandibular condyle, and shoulder are all excluded. If your orthopedic team performs core decompression at the knee or shoulder and bills it under S2325, expect a denial.

Late-stage hip AVN (Stage III or higher, when X-ray changes have occurred) is also experimental. So is post-arthroscopic osteonecrosis.

The adjunctive treatment exclusion list is extensive. Aetna considers all of the following experimental when used to treat AVN in any joint:

#Excluded Procedure
1Autologous bone marrow mononuclear cells, bone marrow concentrate, or bone marrow stem cells
2Autologous platelet concentrate
3Bisphosphonates
+ 15 more exclusions

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Four additional procedure combinations are explicitly experimental:

#Excluded Procedure
1Combined core decompression and bone marrow aspiration concentrate grafting, or intralesional autologous BM-derived cell therapies for osteonecrosis of the femoral head
2Biological augmentation (bone marrow aspiration concentrates, mesenchymal stem cell derivatives, adipose-derived stromal vascular fraction) with retro-drilling core decompression
3Core decompression combined with a biomaterial scaffold (e.g., allograft-bone threaded cage or mineralized collagen threaded scaffold)
+ 1 more exclusions

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

The real issue here is the stem cell and PRP combinations. These are being used in practice and marketed aggressively. If your orthopedic or regenerative medicine group has been billing any of these alongside S2325 for Aetna patients, audit those claims now. The bisphosphonate injections — J1436 (etidronate disodium), J1740 (ibandronate sodium), J2430 (pamidronate disodium), J3489 (zoledronic acid) — are also non-covered under this policy.


Coverage Indications at a Glance

Indication Status Relevant Codes Notes
Early/pre-collapse AVN of the hip, Ficat Stage I or II (femoral head/neck) Covered S2325; M87.151–M87.159, M87.251–M87.256, M87.351–M87.353, M87.851–M87.859, M87.51–M87.59, M90.551–M90.559 Requires documented Ficat staging; verify prior auth by plan
Late/post-collapse AVN of the hip, Stage III or higher Experimental X-ray changes present; not eligible for S2325
AVN of other joints (ankle, elbow, knee, mandibular condyle, shoulder) Experimental All joints except hip excluded
+ 14 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

This policy is now in effect (since 2025-11-01). Verify your claims match the updated criteria above.

Aetna Core Decompression Billing Guidelines and Action Items 2025

#Action Item
1

Audit all active core decompression cases before November 1, 2025. Pull every scheduled or recent case for Aetna patients. Confirm the chart documents Ficat Stage I or II. If staging isn't explicit in the surgical note or pre-op imaging report, get an addendum now.

2

Add Ficat staging to your documentation templates. If your orthopedic surgeons don't routinely record Ficat stage in operative notes, update the template today. This is the single most important documentation element for S2325 reimbursement under this policy.

3

Stop billing adjunctive experimental codes alongside S2325 for Aetna patients. If your group has been bundling PRP (0232T or P9020), bone marrow harvesting (38232), or shockwave therapy (0101T) with core decompression for AVN, those adjunctive codes will deny. They were likely denying before — but now the policy language is explicit.

+ 4 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
+ 1 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT, HCPCS, and ICD-10 Codes for Core Decompression Under CPB 0753

Covered HCPCS Codes (When Selection Criteria Are Met)

Code Type Description
S2325 HCPCS Hip core decompression

Experimental / Not Covered CPT Codes

Code Type Description Status
0101T CPT Extracorporeal shock wave involving musculoskeletal system, not otherwise specified, high energy Experimental
0232T CPT Injection(s), platelet rich plasma, any site, including image guidance, harvesting and preparation Experimental
0481T CPT Injection(s), autologous white blood cell concentrate (autologous protein solution), any site Experimental
+ 2 more codes

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Not Covered HCPCS Codes

Code Type Description
C1763 HCPCS Connective tissue, non-human (includes synthetic)
J1436 HCPCS Injection, etidronate disodium, per 300 mg
J1740 HCPCS Injection, ibandronate sodium, 1 mg
+ 4 more codes

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Key ICD-10-CM Diagnosis Codes

Code Description
M87.0 Osteonecrosis of bone (idiopathic aseptic)
M87.00–M87.050; M87.061–M87.150; M87.161–M87.166; M87.174–M87.179; M87.188–M87.219; M87.231–M87.250; M87.261–M87.319; M87.331–M87.350; M87.361–M87.366; M87.374–M87.819; M87.831–M87.850; M87.861–M87.869; M87.874–M87.9; M90.511–M90.549; M90.561–M90.58–M90.59 Osteonecrosis of bone [excluding femur] — experimental indications
M87.151–M87.159 Osteonecrosis of femur [early/pre-collapse, Stage I or II] — covered under selection criteria
+ 14 more codes

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Get the Full Picture for CPT 38232

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee